Hemogenyx Pharmaceuticals plc

Hemogenyx Pharmaceuticals is a clinical-stage biopharmaceutical group developing new medicines and treatments for life-threatening diseases. Hemogenyx Pharmaceuticals is developing several distinct and complementary product candidates, as well as a platform technology that it uses as an engine for novel product development.
Deal price
2p
Discount of 20.16 %
Last Price 2.505p p

Key information

Key information

Sector

Pharmaceuticals and Biotechnology

Close date

Delivery

Placing price

Last price

Discount

Amount raised

2p

2.505 p

20.16 %

£3,325,000

Use of proceeds

The net proceeds from the Placing will be used to facilitate the development of the Company's Chimeric Antigen Receptor T-cells ("HEMO-CAR-T") for the treatment of acute myeloid leukaemia ("AML").

Important notices

This website contains links to other websites and resources provided by third parties. These links are provided for your information only and we accept no responsibility for them or for any loss or damage that may arise from your use of them.

Investing in financial products involves taking risk. The value of investments can go up as well as down and you may receive back less than your original investment. CMC Markets UK plc trading as CMC CapX (“CMC”) does not provide investment advice of any kind and individual investors should make their own decisions or seek independent advice regarding the merits of entering into, and the suitability of, any investment. Nothing on this website and no communication from CMC should be construed as an investment recommendation. Only professional clients and eligible counterparties are eligible to participate in any offering in connection with CMC's services. There are inherent risks associated with investing in such offerings and such investments should only be made as part of a diversified portfolio. Nothing on this website constitutes an offer to sell, or a solicitation of an offer to buy, any security to any person in any jurisdiction to whom or in which such offer, solicitation or sale is unlawful.

Please read our Risk Warning before making any investment decisions.

Capx

Participate in exclusive deals

Start investing in exclusive deals.